急性与亚急性A型主动脉综合征中的主动脉弓管理
该研究比较了A型主动脉综合征修复术中无弓部干预、半弓置换和全弓置换三种策略的结局。2004至2019年间共634例患者,分为无弓组(n=130)、半弓组(n=397)和全弓组(n=107)。全弓组体外循环和主动脉阻断时间及住院时间最长,但早期死亡率和10年生存率在弓部干预组与无弓组间无显著劣势。
要点
- 全弓组体外循环时间、主动脉阻断时间和住院时间最长(P<.0001)。
- 早期死亡率无弓组20%、半弓组10%、全弓组10%(P=.01)。
- 10年生存率无弓组54%、半弓组66%、全弓组65%(P=.01)。
核心结论
- 尽管体外循环和主动脉阻断时间更长,弓部干预在本系列中未与更差的手术或长期结局相关。
- 外周血管疾病和术前肾功能衰竭仍是A型主动脉夹层修复术后死亡的最高风险因素。
研究设计与样本
- 2004年至2019年间634例因急性A型主动脉夹层需修复的患者,根据弓部干预类型分为无弓组(n=130)、半弓组(n=397)和全弓组(n=107)。
- 主要终点为死亡率,并进行多变量风险因素分析;次要终点为再次手术及早期和晚期并发症。
主要发现
- 队列手术年龄为55±14岁,组间相似(P=.34)。
- 外周动脉疾病、心力衰竭和既往冠状动脉旁路移植术的发生率组间差异有统计学意义(P<.05)。
- 全弓组体外循环时间、主动脉阻断时间和住院时间的中位数最长(P<.0001)。
- 早期死亡率无弓组20%、半弓组10%、全弓组10%(P=.01);10年生存率无弓组54%、半弓组66%、全弓组65%(P=.01)。
- 再次主动脉干预的发生率或时机无差异(P>.05);全队列晚期死亡风险因素包括术前外周动脉疾病(风险比2.3;95%置信区间,1.2至4.4;P=.009)和术前透析(风险比2.8;95%置信区间,1.3至6.1;P=.01)。
关键数值与推荐
- 早期死亡率:无弓组20% vs 半弓组10% vs 全弓组10%(P=.01)。
- 10年生存率:无弓组54% vs 半弓组66% vs 全弓组65%(P=.01)。
- 术前外周动脉疾病晚期死亡风险比2.3(95%置信区间,1.2至4.4;P=.009)。
- 术前透析晚期死亡风险比2.8(95%置信区间,1.3至6.1;P=.01)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this study was to compare the outcomes of no arch intervention, hemiarch replacement, and total arch replacement during type A aortic syndromes in a contemporary series. METHODS: From 2004 to 2019, 634 patients have required acute type A dissection repair; these patients were divided into three groups based on type of arch intervention performed: no arch (n = 130), hemiarch (n = 397), and total arch (n = 107). The primary endpoint was mortality; a multivariable risk factor analysis was performed. Secondary endpoints were reoperation and early and late complications. RESULTS: Operative age was 55 ± 14 years for the cohort and was similar between groups (P = .34). The incidence of peripheral artery disease, heart failure, and prior coronary artery bypass graft surgery differed between the groups (P < .05). Median cardiopulmonary bypass time, aortic cross-clamp time, and length of stay were longest for the total arch group (P < .0001). Early mortality was 20%, 10%, and 10% for the no-arch, hemiarch, and total arch groups, respectively (P = .01). Ten-year survival was 54%, 66%, and 65% for the no-arch, hemiarch, and total arch groups, respectively (P = .01). There was no difference in incidence or timing of redo aortic interventions (P > .05). For the entire cohort, risk factors for late mortality included preoperative peripheral artery disease (hazard ratio 2.3; 95% confidence interval, 1.2 to 4.4; P = .009) and preoperative dialysis (hazard ratio 2.8; 95% confidence interval, 1.3 to 6.1; P = .01). CONCLUSIONS: Despite longer cardiopulmonary bypass and aortic cross-clamp times, arch intervention was not associated with worse operative or long-term outcome in this series. Patients with peripheral vascular disease and preoperative renal failure remain at highest risk for mortality after type A aortic dissection repair.
引用
- Patel PM, Dong A, Chiou E, et al. Aortic Arch Management During Acute and Subacute Type A Aortic Syndromes. Ann Thorac Surg. 2022. PMID: 35085523. doi:10.1016/j.athoracsur.2021.12.064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。